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“By the help of Microscopes, there is
nothing so small as to escape our
inquiry; hence there is a new visible
World discovered to the understanding.”
Thus wrote Robert Hooke in his pioneer-
ing work Micrographia [1] published by
the Royal Society in 1664. In this revolu-
tionary book, Hooke described with
excitement his discoveries using a
simple light microscope, coining the
word ‘cell’ to define  the microscopic
structures he saw in cork and plant
samples. In this issue of Journal of Biology
[2], Claude Lechene and colleagues
describe a 21st century microscopy tech-
nology (Figure 1) that also reveals
images we have never seen before.
Hooke was fascinated by the new
vision of the world and the planets
afforded by the lenses of the early
light microscopes and telescopes of
the 17th century. Ever since these dis-
coveries, researchers have been gazing
at the microscopic world and develop-
ing better and better instruments to do
so. Over the centuries, the demanding
needs of biologists have fuelled
countless improvements in imaging
technologies.  For example, electron
microscopy has become a standard
instrument for high-resolution imaging
(in the nanometer range) in biology,
and scanning probe microscopy
techniques provide three-dimensional
images of atomic surfaces. 
Quantitative imaging with
mass spectrometry 
Lechene, of Harvard Medical School
and Brigham and Women’s hospital in
Boston, USA, knew exactly what
requirements he was looking for in a
quantitative imaging instrument. He
was interested in using stable isotopes
as tracers in biological samples. “To do
that one has to be able to recognize
them by mass spectrometry,” explains
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Background
• Mass spectrometry separates ions of different mass:charge ratios in
order to analyze the composition of a sample. 
• Isobars are nuclides (nuclei of atoms or atomic clusters) of the same
apparent atomic mass (i.e. the same number of neutrons). Isotopes
are different forms of the same element that have the same number of
protons (the same atomic number) but different numbers of neutrons
(different atomic masses).
• The  mass resolution of a particular mass spectrometer is the
smallest difference in atomic mass that can be distinguished by the
instrument. The spatial resolution of a microscope is the smallest
distance that can be resolved using it. The sensitivity of an instrument
is the smallest amount of material that it can detect. 
• Sputtering is the physical process whereby atoms in a solid target
material are ejected into the gas phase as a result of bombardment of
the material by a beam of ions. In secondary-ion mass spectrometry
(SIMS) some of the sputtered atoms or clusters become ionized and
can be analyzed according to their mass:charge ratios, to create a
quantitative atomic mass image of the analyzed material.Lechene (see the ‘Background’ box for
explanations and definitions). “And
there was no instrument to do so.”
During his studies in Paris, Lechene
came across Georges Slodzian of the
Université Paris-Sud in Orsay, a third-
generation disciple of the French school
of electron and ion optics. Slodzian's
work on ion microscopy was a major
input to the development of secondary-
ion mass spectrometry (SIMS) [3],
which is widely used in fields such as
geochemistry, cosmology and materials
sciences. “I needed an instrument that
had high spatial resolution, the ability
to detect several isotopes in parallel
with high sensitivity and, at the same
time, a mass resolution high enough to
separate  isobars like the ones found
with nitrogen compounds,” says
Lechene. 
The ability to look at multiple iso-
topes simultaneously was critical for
assessing isotope ratios and normalizing
one tracer isotope with respect to
another; this is useful, for example, for
distinguishing the isotope label from the
endogenous atoms. The previous gener-
ation of instruments measured only one
isotope at a time. Lechene’s  innovative
vision and Slodzian’s technical wizardry
led to the development of multi-isotope
imaging mass spectrometry (MIMS) (see
‘The bottom line’ box for a summary of
the technology). “Lechene was uniquely
placed to make this development,”
notes John Vickerman of Manchester
University, UK. “He is deeply immersed
in the life-sciences community and has a
long-standing interest in SIMS instru-
mental developments. Slodzian is an
ion physicist of enormous skill and rep-
utation who has been responsible for
the ion-optical design of a number of
extremely successful SIMS instruments.
The new instrument that Slodzian devel-
oped has the spatial resolving power of
an electron microscope with the added
capability of detailed differentiation of
chemical constituents.”
Lechene’s demanding requirements
were important because he was keen to
do experiments using the 15N isotope.
15N had been used for the pioneering
experiments of Schoenheimer [4], to
demonstrate protein turnover, and by
Meselson and Stahl [5], to confirm the
semiconservative nature of DNA repli-
cation. The problem is that nitrogen
atoms hardly ionize and must therefore
be examined as cyanide (CN-) ions.
Lechene needed a system that could
distinguish between the different
isobars, such as 12C15N- (mass 27) and
13C14N- (also mass 27) and other
similar atomic clusters. Slodzian’s
instruments enabled both high spatial
resolution and the high mass resolu-
tion necessary for separating isobars at
high secondary-ion transmissions. 
Once the instrument and the tracer
strategies were in place, the remaining
challenge was developing the func-
tional software and computational
know-how to analyze all the data. Each
image pixel has an intensity that is a
function of the number of ions with a
given mass that are at the pixel address.
Lechene likens an image of 256 x 256
pixels to an array of over 65,000 test
tubes. So, when the researchers analyze
12C, 13C, 14N and 15N, it’s as if each of
those test tubes contains four radioac-
tive compounds. The isotope ratios are
then normalized with respect to each
other and then the peaks are analyzed.
“When I began it took me weeks, if not
months, to do some of the calcula-
tions. And now it takes us minutes,”
says Lechene (see the ‘Behind the
secenes’ box for a summary on the
development of MIMS).
A plethora of applications 
Lechene teamed up with biologists
from different disciplines to demon-
strate how MIMS could be applied to
quantitative imaging of biological
samples. The Lechene study [2] is full
of examples looking at turnover of
proteins, DNA and fatty acids and at
subcellular localization. Although
these are spectacular examples of the
MIMS technique, many researchers
agree that this is just the tip of the
iceberg. “The labelling of the lymph
node cells by 15N is really convincing
and suggests that MIMS may be highly
useful in immunology and cancer
research,” says Brad Amos of the MRC
Laboratory of Molecular Biology in
Cambridge, UK. “The paper shows that
a remarkable amount of fine detail can
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The bottom line
• Multi-isotope imaging mass spectrometry (MIMS) has been developed
from secondary-ion mass spectrometry (SIMS) by adding sophisticated
ion optics, labeling with stable isotopes and quantitative image-analysis
software.
• It is now possible with MIMS to monitor molecules labeled with stable
or radioactive isotopes at a resolution and sensitivity that has not been
possible with other techniques.
• MIMS can distinguish between ions of very similar mass, such as
12C15N- and 13C14N-.
• Several isotopes can be imaged simultaneously using MIMS.
• MIMS can also generate quantitative images of atomic composition
within subcellular compartments in tissue sections or cells without
specific labeling.be seen. This may turn out to be a key
paper in the development of a really
important imaging method.”
“The most significant feature of this
technique is that it opens up a whole
new world of imaging; we haven’t yet
imagined all that we can do with it,”
says Peter Gillespie from the Oregon
Health & Science University in Portland,
USA. He agrees with Amos that the
technology represents an imaging rev-
olution. “The novelty of the technique
means it will take some time for the
details to be absorbed, [but it] sets a
spectacular new standard for spatial
resolution and detection of stable and
radioactive compounds in cells.” Vick-
erman is also enthusiastic about the
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Figure 1
Microscopy through the ages. (a) This illustration, from Robert Hooke’s Micrographia [1], shows the plans for his lens-grinding machine and for his
setup of the microscope. (b) Prototype of the NanoSIMS 50 (Cameca, France) used for MIMS technology.
(a)
(b)applications: “This study is important
in that it demonstrates across a range
of demanding applications that SIMS
can deliver unique information, inac-
cessible by other means.”
But Vickerman adds a cautionary
note about how widely MIMS technol-
ogy will be applied in the future. “It is
clear that the technique has great
potential in medicine and biology, but
there are two issues that have to be
overcome: the conservative approach
of much of the potential user commu-
nity and the cost of the equipment.”
Gillespie agrees “Once commercial
instruments are available, will they be
affordable and easy enough to use that
we will do many experiments with
them? Or will they be like electron
microscopes, where the expense of the
instruments and the difficulty in oper-
ation means that relatively few people
use them well?”
“It may take a long time (EM took
a long time), but I am convinced that
in 10-15 years this will be an easily
accessible technique, with routine
instruments in many departments of
biological research,” responds
Lechene. A machine based on
Slodzian’s prototype is already sold by
a French company called Cameca Inc.,
and Lechene notes that there are over
a dozen around the world. At a cost of
two million dollars they are beyond
the budget of most laboratories. But
Lechene is keen to point out that more
and more mass spectrometry
machines are being purchased. “After
all, it’s just the price of five electron
microscopes, but it does so much
more!”
Perhaps we should leave the last
word to Hooke [1], whose prophecies
echo through three centuries of
improvements in microscopy: “Tis not
unlikely, but that there may be yet
invented several other helps for the
eye, at much exceeding those already
found, as those do the bare eye, such
as by which we may perhaps be able
to discover ... the figures of the com-
pounding Particles of matter and the
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Behind the scenes
Journal of Biology asked Claude Lechene about the development of imaging mass
spectrometry.
What prompted you to embark on the development of the MIMS
technology?
It dates back to my MD studies in France and my work in biological research at
the Commissariat à l’Energie Atomique (CEA) outside Paris. There I learnt and
used tracer techniques with radioactive labels (radioactive sodium and
potassium) coming from the nuclear reactor. I became interested in using
isotopes as tracers and studied transport across cell membranes using electron
probe microanalysis. There was a man there called Georges Slodzian who was
developing ion microscopy technology. He finally invented the generation of
instruments that offered the high spatial resolution I needed for biology and
which was able to measure several tracers simultaneously. This allowed us to
measure isotope ratios and do truly quantitative analysis on the system. For me,
MIMS is not just an imaging instrument; for me, it is a measuring instrument - on
this account it is unique. The imaging tells us where there is something at a
subcellular resolution. But its real beauty is to be able to do precise quantitation.
Suddenly, we have the ability to see and measure things that we could not see or
measure before.
How long did the study take and what were the difficult steps you
encountered?
Although we began dabbling with MIMS in 1998, these studies really took off in
February 2003, after all initial difficulties with the prototype SIMS instruments
were resolved and some quantitative image analysis software was developed.
These advances resulted from a convergence of the work on secondary ion mass
spectrometry in Slodzian’s group and my experience in tracers and micro-
manipulation. We had to learn how to play with the samples, how to do the
experiments with tracers and the calculations, etc. And the software
development was the other essential part. The limiting parameter has become
not the machine but the ability to analyze the reams of data that we get.
What was your initial reaction to the results, and how were they
received by others?
When we finally got what I wanted, I found it even more exciting than I had ever
imagined. And this has not stopped. For us it is marvellous; we see new stuff that
no one has ever seen before and we really say “ooh!”. People have begun to
show an interest; it is a sigmoid increase and I think we are at the little shoulder
of a very steep increase. You know what our colleagues are like when they don’t
know a method - and this one is difficult to understand. But there is more and
more excitement in the biology community. 
What are the next steps?
One avenue is metabolic studies and subcellular localization. This includes basic
studies of transport of fatty acids to any position in the cell or monitoring the
turnover of proteins, nucleotides or sugars in the whole cell in three dimensions.
These applications go from basic science to diagnosis or drug localization studies.
The second direction which we’re pushing is the permanent or long-term
labeling of cells to do cell-fate analysis. We have several ongoing collaborations to
look at immunology, transplantation and stem cells. These are potentially quite
exciting. We are also doing experiments where we take thousands of images of a
single cell, slowly ‘shaving’ off layers from the top to the bottom, and then
reconstruct them to create a three-dimensional representation of the entire cell,
with distinct subcellular locations accessible for quantitative measurements.particular Schematisms and Textures
of Bodies.”
References
1. Hooke R: Micrographia: some physiological
descriptions of minute bodies made by mag-
nifying glasses with observations and inquiries
thereupon. London: Royal Society; 1664.
2. Lechene C, Hillion F, McMahon G,
Benson D, Kleinfeld AM, Kampf JP, Distel
D, Luyten Y, Bonventre J, Hentschel D,
Park KM, Ito S, Schwartz M, Benichou G,
Slodzian G: High resolution quantita-
tive imaging of mammalian and bac-
terial cells using stable isotope mass
spectrometry. J Biol 2006, 5:20.
3. Castaing R, Slodzian G: Microanalyse
par emission ionique secondaire.
J Microsc 1962, 1:31-38.
4. Schoenheimer, R: The dynamic state of
body constituents. Cambridge: Harvard
University Press; 1942. 
5. Meselson M, Stahl FW: The replication
of DNA in Escherichia coli. Proc Natl
Acad Sci USA 1958, 44:671-682. 
Jonathan B Weitzman is a professor at the Univer-
sité Paris 7 Denis Diderot, Paris, France.  
Email: jonathanweitzman@hotmail.com
http://jbiol.com/content/5/6/17 Journal of Biology 2006, Volume 5, Article 17 Author 17.5
Journal of Biology 2006, 5:17